GAL and colorectal carcinoma: In multivariate analysis, high GAL expression was an independent prognostic factor for 5-OS and 5-RFS in patients with stage II CRC (5-OS: HR, 7.31; 95% CI, 2.38–24.04; P<0.001; 5-RFS: HR, 3.99; 95% CI, 1.61–9.44; P=0.004) (Table II), but not in patients with stage III CRC.